Rate My Professor Rakesh Naidu

Naidu's research specializes in the molecular biology of cancer, cancer therapeutics, and cancer venomics. His work investigates molecular alterations leading to breast, prostate, and colon cancers, utilizing genomics, proteomics, transcriptomics via high-density microarrays, sequencing, and mass spectrometry to identify biomarkers and anti-cancer mechanisms. He explores synthetic diarylpentanoids, natural compounds, and venom-derived components for their anti-cancer activities in various human cancer cells. As principal investigator, he has secured grants such as Genetic Analysis of a Selected Gene in Breast Cancer (2004-2006) and Mechanisms of Action of Selected Bioactive Synthetic Diarylpentanoids on Human Colorectal Cancer Cells (2011-2013). Key publications include "Immunohistochemistry of C-MYC In Breast Carcinoma" (2004), "Human Telomerase Reverse Transcriptase Gene Amplification in Breast Tumors" (2006), "Antileukemic Properties of Curcumin and Diarylpentanoid Analogue on Bcr-Abl-Positive Leukemic Cells" (2025), and "Gut microbial metabolites targeting JUN in renal cell carcinoma via IL-17 signaling pathway: a network pharmacology approach" (2026). He received the AACR-NCI International Investigator Opportunity Grant (2008) and recent teaching awards: PVC's Commendation for Excellence in Education (2025), Most Inspiring Supervisor (2022), and Outstanding Supervision and Educational Excellence (2023).